We are pleased to once again deliver your roundup of news and developments across the intellectual property landscape in Australia and New Zealand.
In this edition of IP Spotlight, we continue to keep you up to date with IP Australia’s ongoing COVID-19 relief measures. We look at recent decisions made by the Federal Court and IP Australia concerning the pharmaceutical industry, and we also discuss a further decision over coffee.
If any of our articles raise questions or concerns regarding your IP or practice, please get in touch with Wrays.
For now, enjoy the read.
